Data as of Aug 29
| +0.02 / +0.38%|
The 3 analysts offering 12-month price forecasts for China Cord Blood Corp have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 6.00. The median estimate represents a +14.29% increase from the last price of 5.25.
The current consensus among 3 polled investment analysts is to Buy stock in China Cord Blood Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.